Active

Powering down: Targeting the cancer cell batteries to stop cancer

Cancer types:

General cancer research

Project period:

Research institute:

Ben Gurion University of the Negev

Award amount:

£191,800

Location:

Israel

Barak Rotblat Headshot
Researcher Dr Barak Rotblat

Dr Rotblat and his team are investigating whether a special type of molecular protein that cancer cells use when they generate energy could be an important new target for cancer treatments.

Hope for the future

Cancer cells need huge amounts of energy to survive and grow. Understanding how they generate that energy is vital for figuring out new ways to stop cancer. 

Dr Rotblat is investigating an important set of molecules, called ‘chaperone proteins’, that are involved in this process. His findings should help us find out more about exactly how cancer works, and how cancer cells make the energy they need. This information could provide those vital first steps towards developing a new treatment for cancer.   

Barak Rotblat and Team in the lab
Meet the scientist

Barak is the father of a boy and a girl, and he lives with his wife and kids in a small kibbutz in the south of Israel. Before we lived in Leicester, UK, for two years while in my postdoc, and learned to love British culture. His hobbies are rock climbing, listening to music and reading. He loves sci-fi such as Dune

The science

Chaperone proteins work as the ‘maintenance crew’ inside the ‘batteries’ of the cell, called the mitochondria. They help to guide other important proteins around the mitochondria, and make sure these proteins are working properly. This helps the mitochondria to quickly ‘power up’ and produce more energy as soon as the cancer cell needs it. 

Dr Roblat and his team in Israel think that blocking chaperone proteins might make it harder for cancer cells to produce energy in a flexible way. But they need more evidence to know for sure.  Thanks to your support, the team can now gather that evidence, and study in detail exactly how cancer cells use chaperone proteins. As part of this work they will use a special molecular technique to remove these proteins from cancer cells, and then study in the lab how this affects cancer growth and survival. 

Building up a detailed picture of exactly how chaperone proteins work in cancer will help to reveal whether they could be a new target for cancer treatments. These findings will also be immensely valuable to other researchers searching for new ways to treat cancer. 

What I think is special about Worldwide Cancer Research is that it gives out-of-the-box research ideas a fair chance. I have great hopes for this project. Our findings will lay the scientific infrastructure for developing new therapeutic strategies in the future.

Barak Rotblat Headshot
Dr Barak Rotblat

Related projects

Andres Hidalgo Headshot

Active Spain

Lung cancer

How do cancer cells modify white blood cells to help tumours grow?

Researchers want to help immunotherapy work for more cancer patients by understanding how cancers hijack our immune system and preventing this happening 

Researcher: Dr Andrés Hidalgo

Understanding how cancer cells modify white blood cells to help tumours grow
Andrew Beekman and Team

Active United Kingdom

General cancer research

Can we stop cancer becoming resistant to chemotherapy?

Chemotherapy can sometimes stop working, so this project is hoping to better understand why and find ways to give more, better options to cancer patients.

Researcher: Dr Andrew Beekman

Stopping cancer becoming resistant to chemotherapy
Tim Elliott and Team

Active United Kingdom

General cancer research

Can we predict which patients will respond to immunotherapy?

This project hopes to open up exciting possibilities for personalised cancer treatment by finding how to predict which patients will respond best to treatment.

Researcher: Professor Tim Elliott

Finding ways to predict which patients will respond to immunotherapy
Share this page